Tablet comprising fluvastatin and carmellose calcium

Details for Australian Patent Application No. 2004251439 (hide)

Owner Novartis AG

Inventors Uehara, Tomoyuki; Kitaoka, Kenichi; Taguchi, Kenji

Agent Davies Collison Cave

Pub. Number AU-B-2004251439

PCT Pub. Number WO2005/000276

Priority 2003-181349 25.06.03 JP

Filing date 24 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 11 September 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/405 (2006.01)

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000276 Priority application(s): WO2005/000276

11 September 2008 Application Accepted

  Published as AU-B-2004251439

22 January 2009 Standard Patent Sealed

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251444-Cancer treatment with epothilones

2004251435-Inhibitors of histone deacetylases for the SUPPRESSION THERAPY of diseases